BioSpace News Archive

Simulations Plus, Inc. (Nasdaq: SLP), today announced a new funded collaboration with a large pharmaceutical company to modify the GastroPlus® Advanced Compartmental Absorption and Transit (ACAT™) model in support of ongoing research programs for the treatment of gastrointestinal diseases.

Natera, Inc. (NASDAQ: NTRA), a leader in personalized genetic testing and diagnostics, today announced the publication of the landmark SMART study in the American Journal of Obstetrics and Gynecology (AJOG), one of the world’s leading Obstetrics and Gynecology medical journals.

enVVeno Medical Corporation announced that Robert Berman, Chief Executive Officer of enVVeno, will present at the Virtual Investor 2022 Top Picks Conference on Tuesday, January 25, 2022 at 1:00 PM ET.

CNS Pharmaceuticals, Inc. announced that John Climaco, Chief Executive Officer of CNS Pharmaceuticals, will participate in the Virtual Investor 2022 Top Picks Conference on Wednesday, January 26, 2022 at 11:00 AM ET.

Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), announced today that the first group of 15 patients have been enrolled and dosed in a Phase 2b viral challenge study (RVL-VRL01) to evaluate the efficacy of intranasal REVTx-99 for the preventive treatment of H3N2 influenza (influenza A) infection in healthy humans.

BENDIT Technologies, a company focused on the development of steerable microcatheters, announced today the successful first use in the USA of the BENDIT21 neuro catheter in a life-saving treatment.

In its 14th year, Biotech Showcase™, co-produced by Demy-Colton and EBD Group, welcomed over 2,400 attendees, nearly a 10 percent increase from last year, together with over 860 investors, and 320 presenting companies.

Ambys Medicines, a company pioneering cell-based therapies for severe liver diseases, today announced the appointment of Corinne Foo-Atkins, MBBS, MBA, MSc, as the company’s first Chief Strategy Officer.

As Americans brace themselves for year three of pandemic life, their mental health hits an all-time low, according to the Mental Health Index: U.S. Worker Edition. Most notably, PTSD, depression and addiction soar amid skyrocketing cases of Omicron.

GenomiCare Biotechnology, a leader in precision medicine of Chinese cancer patients and the application of RWD to pharmaceutical research and development, announced the recent appointment of Shusen Liu, M.D., Ph.D., as Chief Medical Officer.